Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS

v3.21.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2021
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

8. SUBSEQUENT EVENTS

Acquisition

On April 30, 2021, the Company completed its acquisition of Sentry Neuromonitoring, LLC (“Sentry”), one of the largest IONM service providers in Texas, for an aggregate purchase price of $3.5 million. The purchase price to be paid is $1.225 million in cash, payable in installments, and $2.3 million in Assure common stock, payable $1.625 million at closing and $650 thousand into escrow, subject to escrow release. The common stock is subject to 12-month lockup and applicable securities laws and regulations.

Board Appointment

On April 15, 2021, the Company appointed a new member to its Board of Directors. In connection with the appointment, the Company

granted 150,000 stock options exercisable to acquire common stock at $1.12 per share for a period of five years.

Nasdaq listing

On May 12, 2021, we filed an application to be listed on the Nasdaq.